ROBERT PARSONS: Open Payments
NPI 1588625081 · YOUNGSTOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$69,368 in 303 payments from 14 companies in 2025. Trend: 2023 $13,117 · 2024 $14,454 · 2025 $69,368
Speaker / faculty: $43,840Travel & lodging: $12,979Consulting: $6,960Food & beverage: $5,588
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 130 | $66,958 |
| Otsuka America Pharmaceutical, Inc. | 36 | $485 |
| Vanda Pharmaceuticals Inc. | 36 | $385 |
| Lundbeck LLC | 23 | $297 |
| Teva Pharmaceuticals USA, Inc. | 22 | $281 |
| ABBVIE INC. | 19 | $272 |
| Neurocrine BioSciences, Inc. | 10 | $202 |
| Alkermes, Inc. | 10 | $182 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $131 |
| Janssen Pharmaceuticals, Inc | 5 | $96 |
Products named: COBENFY, FANAPT, REXULTI, ABILIFY MAINTENA, VRAYLAR, INGREZZA, AUSTEDO XR, ARISTADA.
Industry payments across OH — which companies pay providers there.
